Isla E. Emmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isla E. Emmen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- David H. O'COnnor
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
9 shared publications - Nancy Wilson
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, 5510 Elements Way Suite #500, Madison, WI 53719, USA
9 shared publications - Nicholas R. Minor
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA
7 shared publications - Thomas C. Friedrich
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
7 shared publications - Andrew J. Lail
Department of Pathology and Laboratory Medicine , University of Wisconsin-Madison , 5510 Element Way, Madison 53719 , Wisconsin, USA , wisc.edu
6 shared publications - William C. Vuyk
Affiliation School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States of America
6 shared publications
Latest Publications
- Open Access
Air sampling in team congregate spaces for early detection of respiratory virus threats at the 2026 FIFA World Cup™
Background: Respiratory infections are the leading cause of illness at major sporting events, yet surveillance relies on athletes recognising and reporting symptoms, missing asymptomatic, pre-symptomatic and unreported infections. During competitions, teams are housed together and share spaces with members of the broader community. Aim: To evaluate whether continuous air sampling with point-of-care testing could detect respiratory-virus nucleic acids in an elite team’s congregate spaces during competition, and whether the signals were operationally useful. Methods: Prospective, descriptive environmental-surveillance study following the Canadian men’s national soccer team across five host cities during the 2026 FIFA World Cup™ (3 June to 4 July 2026). InBio Apollo bioaerosol samplers ran continuously in up to four team-designated rooms per hotel (physiotherapy, meal, equipment and coaches’ room or hallway); filters were changed approximately twice daily, eluted on-site and tested with the Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV plus assay. A sample was considered positive if any cycle-threshold (Ct) value was reported, as less than 45, for a target. Results: Of 174 air filters, 13 yielded detections of viral genetic material (9 SARS-CoV-2, 3 influenza A virus, 1 influenza B virus, 0 RSV). Detections were sparse early and clustered late in the tournament. An influenza A signal appeared the morning a player was sent home febrile, and SARS-CoV-2 signals coincided with visibly ill hotel staff, with signals falling after ill staff were excluded. Conclusion: Air sampling with point-of-care testing is feasible in the context of an elite team and can surface behavior-independent viral signals during competition that may offer opportunities for earlier precautionary actions. Key public health message: What did you want to address in this study and why?: Respiratory infections are the most common illness at major sporting events, but they are usually found only when someone notices symptoms and reports them. That misses infections in people who feel well or who choose not to say anything. We hypothesized that sampling and quickly testing the air of the shared rooms a national team occupies in a hotel would identify respiratory viruses, and that this could provide a behaviour-independent tool for improving elite athlete health. What have we learnt from this study?: Air sampling with same-day testing worked in practice across five host cities and a month of competition. Most samples were negative, but viral genetic material was found in team rooms in every city. Some signals coincided with a febrile player and visibly unwell hotel staff. What are the implications of your findings for public health?: Air sampling is a practical way to watch a shared indoor space for respiratory viruses without testing individuals or collecting personal data. When viruses are detected in a room, low-cost precautions such as ventilation, air cleaning or excluding unwell staff can be implemented. The same approach could be used for teams, delegations, and other groups housed together at mass gatherings in Europe and elsewhere.
Open AccessAir sampling in team congregate spaces for early detection of respiratory virus threats at the 2026 FIFA World Cup™
Background: Respiratory infections are the leading cause of illness at major sporting events, yet surveillance relies on athletes recognising and reporting symptoms, missing asymptomatic, pre-symptomatic and unreported infections. During competitions, teams are housed together and share spaces with members of the broader community. Aim: To evaluate whether continuous air sampling with point-of-care testing could detect respiratory-virus nucleic acids in an elite team’s congregate spaces during competition, and whether the signals were operationally useful. Methods: Prospective, descriptive environmental-surveillance study following the Canadian men’s national soccer team across five host cities during the 2026 FIFA World Cup™ (3 June to 4 July 2026). InBio Apollo bioaerosol samplers ran continuously in up to four team-designated rooms per hotel (physiotherapy, meal, equipment and coaches’ room or hallway); filters were changed approximately twice daily, eluted on-site and tested with the Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV plus assay. A sample was considered positive if any cycle-threshold (Ct) value was reported, as less than 45, for a target. Results: Of 174 air filters, 13 yielded detections of viral genetic material (9 SARS-CoV-2, 3 influenza A virus, 1 influenza B virus, 0 RSV). Detections were sparse early and clustered late in the tournament. An influenza A signal appeared the morning a player was sent home febrile, and SARS-CoV-2 signals coincided with visibly ill hotel staff, with signals falling after ill staff were excluded. Conclusion: Air sampling with point-of-care testing is feasible in the context of an elite team and can surface behavior-independent viral signals during competition that may offer opportunities for earlier precautionary actions. Key public health message: What did you want to address in this study and why?: Respiratory infections are the most common illness at major sporting events, but they are usually found only when someone notices symptoms and reports them. That misses infections in people who feel well or who choose not to say anything. We hypothesized that sampling and quickly testing the air of the shared rooms a national team occupies in a hotel would identify respiratory viruses, and that this could provide a behaviour-independent tool for improving elite athlete health. What have we learnt from this study?: Air sampling with same-day testing worked in practice across five host cities and a month of competition. Most samples were negative, but viral genetic material was found in team rooms in every city. Some signals coincided with a febrile player and visibly unwell hotel staff. What are the implications of your findings for public health?: Air sampling is a practical way to watch a shared indoor space for respiratory viruses without testing individuals or collecting personal data. When viruses are detected in a room, low-cost precautions such as ventilation, air cleaning or excluding unwell staff can be implemented. The same approach could be used for teams, delegations, and other groups housed together at mass gatherings in Europe and elsewhere.
- Open Access
- 13 February 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 253, 108712
Detection of SARS-CoV-2 in aerosol and surface samples in high acuity hospital settings during community epidemic waves – implications for risk-based infection control
- 13 February 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 253, 108712
Open AccessDetection of SARS-CoV-2 in aerosol and surface samples in high acuity hospital settings during community epidemic waves – implications for risk-based infection control
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 6154094
Describing a Persistent SARS‐CoV‐2 Infection Outcomes and Mutations Associated With B‐Cell Deficiency: A Case Report
Background: Immunocompromised (IC) individuals are at an increased risk for persistent SARS‐CoV‐2 infections and can develop new viral mutations and lineages not seen in the community. In this case report, a persistent SARS‐CoV‐2 infection (330 days) in an IC patient is examined for viral mutations and mutations associated with cryptic lineages. Case Presentation: The patient was followed up in a longitudinal study examining persistent SARS‐CoV‐2 in IC patients. The patient provided stool and nasal swab samples biweekly until 28 days postenrollment, then monthly, and then quarterly after 12 months post enrollment until the participant was no longer positive for SARS‐CoV‐2. Staff performed RT‐qPCR and viral sequencing on the samples. Viral mutations from the XBK lineage were already present in the initial sample. By the end of the infection period, there were 40 fixed consensus changes from XBK of which two mutations were typical for cryptic lineages. Mutations increased steadily over time, with most mutations fixed by day 253, including the cryptic typical mutations. Conclusion: This case demonstrates the potential for persistent SARS‐CoV‐2 infections to develop mutations and lineages in IC patients and highlights the need for continued SARS‐CoV‐2 monitoring and treatment in this vulnerable population.
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 6154094
Open AccessDescribing a Persistent SARS‐CoV‐2 Infection Outcomes and Mutations Associated With B‐Cell Deficiency: A Case Report
Background: Immunocompromised (IC) individuals are at an increased risk for persistent SARS‐CoV‐2 infections and can develop new viral mutations and lineages not seen in the community. In this case report, a persistent SARS‐CoV‐2 infection (330 days) in an IC patient is examined for viral mutations and mutations associated with cryptic lineages. Case Presentation: The patient was followed up in a longitudinal study examining persistent SARS‐CoV‐2 in IC patients. The patient provided stool and nasal swab samples biweekly until 28 days postenrollment, then monthly, and then quarterly after 12 months post enrollment until the participant was no longer positive for SARS‐CoV‐2. Staff performed RT‐qPCR and viral sequencing on the samples. Viral mutations from the XBK lineage were already present in the initial sample. By the end of the infection period, there were 40 fixed consensus changes from XBK of which two mutations were typical for cryptic lineages. Mutations increased steadily over time, with most mutations fixed by day 253, including the cryptic typical mutations. Conclusion: This case demonstrates the potential for persistent SARS‐CoV‐2 infections to develop mutations and lineages in IC patients and highlights the need for continued SARS‐CoV‐2 monitoring and treatment in this vulnerable population.
- Open Access
- 13 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325203
Amplicon sequencing of pasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle
Highly pathogenic avian influenza (HPAI) viruses with H5 hemagglutinin (HA) genes (clade 2.3.4.4b) are causing an ongoing panzootic in wild birds. Circulation of these viruses is associated with spillover infections in multiple species of mammals, including a large, unprecedented outbreak in American dairy cattle. Before widespread on-farm testing, there was an unmet need for genomic surveillance. Infected cattle can shed high amounts of HPAI H5N1 viruses in milk, allowing detection in pasteurized retail dairy samples. Over a 2-month sampling period in one Midwestern city, we obtained dairy products processed in 20 different states. Here we demonstrate that a tiled-amplicon sequencing approach produced over 90% genome coverage at greater than 20x depth from 5 of 13 viral RNA positive samples, with higher viral copies corresponding to better sequencing success. The sequences clustered phylogenetically within the rest of the cattle outbreak sequences reported. A combination of RT-qPCR testing and sequencing from retail dairy products can be a useful component of a One Health framework for responding to the avian influenza outbreak in cattle.
- 13 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325203
Open AccessAmplicon sequencing of pasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle
Highly pathogenic avian influenza (HPAI) viruses with H5 hemagglutinin (HA) genes (clade 2.3.4.4b) are causing an ongoing panzootic in wild birds. Circulation of these viruses is associated with spillover infections in multiple species of mammals, including a large, unprecedented outbreak in American dairy cattle. Before widespread on-farm testing, there was an unmet need for genomic surveillance. Infected cattle can shed high amounts of HPAI H5N1 viruses in milk, allowing detection in pasteurized retail dairy samples. Over a 2-month sampling period in one Midwestern city, we obtained dairy products processed in 20 different states. Here we demonstrate that a tiled-amplicon sequencing approach produced over 90% genome coverage at greater than 20x depth from 5 of 13 viral RNA positive samples, with higher viral copies corresponding to better sequencing success. The sequences clustered phylogenetically within the rest of the cattle outbreak sequences reported. A combination of RT-qPCR testing and sequencing from retail dairy products can be a useful component of a One Health framework for responding to the avian influenza outbreak in cattle.
- 6 May 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (5) , 922-930
Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection
- 6 May 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (5) , 922-930
Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection
- Open Access
Pasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle
Highly pathogenic avian influenza (HPAI) viruses with H5 hemagglutinin (HA) genes (clade 2.3.4.4b) are causing an ongoing panzootic in wild birds. Circulation of these viruses is associated with spillover infections in multiple species of mammals, including a large, unprecedented outbreak in American dairy cattle. With limited testing of dairy herds, there is an unmet need for genomic surveillance. Infected cattle can shed high amounts of HPAI H5N1 viruses in milk, allowing detection in pasteurized retail dairy samples. Over a 2-month sampling period in one Midwestern city, we obtained dairy products processed in 20 different states. Here we demonstrate that a tiled-amplicon sequencing approach produced over 90% genome coverage at greater than 20x depth from 5 of 13 viral RNA positive samples. A combination of RT-qPCR testing and sequencing from retail dairy products can be a useful component of a One Health framework for responding to the avian influenza outbreak in cattle.
Open AccessPasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle
Highly pathogenic avian influenza (HPAI) viruses with H5 hemagglutinin (HA) genes (clade 2.3.4.4b) are causing an ongoing panzootic in wild birds. Circulation of these viruses is associated with spillover infections in multiple species of mammals, including a large, unprecedented outbreak in American dairy cattle. With limited testing of dairy herds, there is an unmet need for genomic surveillance. Infected cattle can shed high amounts of HPAI H5N1 viruses in milk, allowing detection in pasteurized retail dairy samples. Over a 2-month sampling period in one Midwestern city, we obtained dairy products processed in 20 different states. Here we demonstrate that a tiled-amplicon sequencing approach produced over 90% genome coverage at greater than 20x depth from 5 of 13 viral RNA positive samples. A combination of RT-qPCR testing and sequencing from retail dairy products can be a useful component of a One Health framework for responding to the avian influenza outbreak in cattle.
- Open Access
Longitudinal Assessment of Solid Organ Transplant Recipients with SARS-CoV-2 Infection
Background: Compared to immunocompetent individuals, those who are immunocompromised, including solid organ transplant (SOT) recipients, have higher SARS-CoV-2-related morbidity and mortality. We determined the duration of SARS-CoV-2 RNA positivity to evaluate viral persistence in SOT recipients. Methods: This study prospectively followed SOT recipients who recently tested positive for SARS-CoV-2. The duration of viral RNA shedding in nasal swabs and stool samples was tracked, and viral genome sequencing was performed where possible. Persistent infection was defined as a positive nucleic acid amplification test (NAAT) for SARS-CoV-2 at 28 days or later after initial infection. This duration was chosen based on the CDC recommendation that immunocompromised individuals isolate for at least 20 days 1 , compared to 10 days for non-immunocompromised individuals. Results: Of 30 SOT recipients, 12 (40%) had SARS-CoV-2 RNA in nasal swabs or stool 28 or more days after the first positive SARS-CoV-2 test. IC-015 had high viral loads (Ct1 , compared to 10 days for non-immunocompromised individuals. In 12 of 30 SOT subjects, SARS-CoV-2 RNA was detected at or beyond 28 days post-detection (dpd), despite vaccination and antibody and/or antiviral treatment in most participants. Three subjects tested positive for SARS-CoV-2 RNA past 50 dpd. The CDC recommendation for 20 days of isolation may be insufficient for SOT recipients. Viral persistence in the setting of host immune suppression, coupled with exposure to antiviral treatments, raises concern about the selection of unusual viral variants. Visual
Open AccessLongitudinal Assessment of Solid Organ Transplant Recipients with SARS-CoV-2 Infection
Background: Compared to immunocompetent individuals, those who are immunocompromised, including solid organ transplant (SOT) recipients, have higher SARS-CoV-2-related morbidity and mortality. We determined the duration of SARS-CoV-2 RNA positivity to evaluate viral persistence in SOT recipients. Methods: This study prospectively followed SOT recipients who recently tested positive for SARS-CoV-2. The duration of viral RNA shedding in nasal swabs and stool samples was tracked, and viral genome sequencing was performed where possible. Persistent infection was defined as a positive nucleic acid amplification test (NAAT) for SARS-CoV-2 at 28 days or later after initial infection. This duration was chosen based on the CDC recommendation that immunocompromised individuals isolate for at least 20 days 1 , compared to 10 days for non-immunocompromised individuals. Results: Of 30 SOT recipients, 12 (40%) had SARS-CoV-2 RNA in nasal swabs or stool 28 or more days after the first positive SARS-CoV-2 test. IC-015 had high viral loads (Ct1 , compared to 10 days for non-immunocompromised individuals. In 12 of 30 SOT subjects, SARS-CoV-2 RNA was detected at or beyond 28 days post-detection (dpd), despite vaccination and antibody and/or antiviral treatment in most participants. Three subjects tested positive for SARS-CoV-2 RNA past 50 dpd. The CDC recommendation for 20 days of isolation may be insufficient for SOT recipients. Viral persistence in the setting of host immune suppression, coupled with exposure to antiviral treatments, raises concern about the selection of unusual viral variants. Visual
- Open Access
SARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests
In the United States, SARS-CoV-2 genomic surveillance initially relied almost entirely on residual diagnostic specimens from nucleic acid amplification-based tests (NAATs). The use of NAATs waned after the end of the COVID-19 Public Health Emergency. We partnered with local- and state-level public health agencies and the Dane County Public Library System to continue genomic surveillance by obtaining SARS-CoV-2 genome sequences from freely available community rapid antigen tests (RATs). From August 15, 2023 to February 29, 2024 we received 227 tests, from which we generated 127 sequences with >10x depth of coverage for ≥90% of the genome. In a subset of tests, lower Ct values correlated with sequence success. Our results demonstrate that collecting and sequencing from RATs in partnership with community sites is a practical approach for sustaining SARS-CoV-2 genomic surveillance.
Open AccessSARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests
In the United States, SARS-CoV-2 genomic surveillance initially relied almost entirely on residual diagnostic specimens from nucleic acid amplification-based tests (NAATs). The use of NAATs waned after the end of the COVID-19 Public Health Emergency. We partnered with local- and state-level public health agencies and the Dane County Public Library System to continue genomic surveillance by obtaining SARS-CoV-2 genome sequences from freely available community rapid antigen tests (RATs). From August 15, 2023 to February 29, 2024 we received 227 tests, from which we generated 127 sequences with >10x depth of coverage for ≥90% of the genome. In a subset of tests, lower Ct values correlated with sequence success. Our results demonstrate that collecting and sequencing from RATs in partnership with community sites is a practical approach for sustaining SARS-CoV-2 genomic surveillance.
- Open Access
- 11 March 2024
- Published by Elsevier in The Lancet Microbe
- Vol. 5 (4) , e335-e344
Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
- 11 March 2024
- Published by Elsevier in The Lancet Microbe
- Vol. 5 (4) , e335-e344
Open AccessTracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
- Open Access
Human origin ascertained for SARS-CoV-2 Omicron-like spike sequences detected in wastewater: a targeted surveillance study of a cryptic lineage in an urban sewershed
Summary: Background: The origin of novel SARS-CoV-2 spike sequences found in wastewater, without corresponding detection in clinical specimens, remains unclear. We sought to determine the origin of one such “cryptic” wastewater lineage by tracking and characterizing its persistence and genomic evolution over time. Methods: We first detected a cryptic lineage in Wisconsin municipal wastewater in January 2022. By systematically sampling wastewater from targeted sub-sewershed lines and maintenance holes using compositing autosamplers, we traced this lineage (labeled WI-CL-001) to its source at a single commercial building. There we detected WI-CL-001 at concentrations as high as 2.7 × 10 9 genome copies per liter (gc/L) via RT-dPCR. In addition to using metagenomic 12s rRNA sequencing to determine the virus’s host species, we also sequenced SARS-CoV-2 spike receptor binding domains (RBDs), and where possible, whole viral genomes to identify and characterize the evolution of this lineage over the 13 consecutive months that it was detectable. Findings: The vast majority of 12s rRNAs sequenced from wastewater leaving the identified source building were human. Additionally, we generated over 100 viral RBD and whole genome sequences from wastewater samples containing the cryptic lineage collected between January 2022 and January 2023. These sequences contained a combination of fixed nucleotide substitutions characteristic of Pango lineage B.1.234, which circulated in humans in Wisconsin at low levels from October 2020 to February 2021. Despite this, mutations in the spike gene, and elsewhere, resembled those subsequently found in Omicron variants. Interpretation: We propose that prolonged detection of WI-CL-001 in wastewater represents persistent shedding of SARS-CoV-2 from a single human initially infected by an ancestral B.1.234 virus. The accumulation of convergent “Omicron-like” mutations in WI-CL-001’s ancestral B.1.234 genome likely reflects persistent infection and extensive within-host evolution. Funding: The Rockefeller Foundation, Wisconsin Department of Health Services, Centers for Disease Control and Prevention (CDC), National Institute on Drug Abuse (NIDA), and the Center for Research on Influenza Pathogenesis and Transmission. Research in context: Evidence before this study: To identify other studies that characterized unusual wastewater-specific SARS-CoV-2 lineages, we conducted a PubMed search using the keywords “cryptic SARS-CoV-2 lineages” or “novel SARS-CoV-2 lineages” in addition to “wastewater” on May 9, 2023. From the 18 papers retrieved, only two reported wastewater-specific cryptic lineages. These lineages were identified by members of our author team in wastewater from California, Missouri, and New York City. None of these could be definitively traced to a specific source. A third study in Nevada identified a unique recombinant variant (designated Pango lineage XL) in wastewater, which was also discovered in two clinical specimens from the same community. However, it was unclear whether the clinical specimens collected were from the same individual(s) responsible for the virus detected in the wastewater. To our knowledge, no prior study has successfully traced novel SARS-CoV-2 lineages detected in wastewater back to a specific location. How and where cryptic lineages are introduced into wastewater is not known. The added value of this study: This study documents the presence and likely source of a novel and highly divergent cryptic SARS-CoV-2 lineage detected in Wisconsin wastewater for 13 months. In contrast to previously reported cryptic lineages, we successfully traced the lineage (WI-CL-001) to a single commercial building with approximately 30 employees. The exceptionally high viral RNA concentrations at the source building facilitated the tracing effort and allowed for the sequencing of WI-CL-001’s whole genome, expanding our view of the lineage’s mutational landscape beyond the spike gene. Implications of all the available evidence: WI-CL-001’s persistence in wastewater, its heavily mutated Omicron-like genotype, and its identified point source at a human-occupied commercial building all support the hypothesis that cryptic wastewater lineages can arise from persistently infected humans. Because cryptic wastewater lineages have some amino acid changes that subsequently emerge in circulating viruses, increased global monitoring of such lineages could help forecast variants that may arise in the future.
Open AccessHuman origin ascertained for SARS-CoV-2 Omicron-like spike sequences detected in wastewater: a targeted surveillance study of a cryptic lineage in an urban sewershed
Summary: Background: The origin of novel SARS-CoV-2 spike sequences found in wastewater, without corresponding detection in clinical specimens, remains unclear. We sought to determine the origin of one such “cryptic” wastewater lineage by tracking and characterizing its persistence and genomic evolution over time. Methods: We first detected a cryptic lineage in Wisconsin municipal wastewater in January 2022. By systematically sampling wastewater from targeted sub-sewershed lines and maintenance holes using compositing autosamplers, we traced this lineage (labeled WI-CL-001) to its source at a single commercial building. There we detected WI-CL-001 at concentrations as high as 2.7 × 10 9 genome copies per liter (gc/L) via RT-dPCR. In addition to using metagenomic 12s rRNA sequencing to determine the virus’s host species, we also sequenced SARS-CoV-2 spike receptor binding domains (RBDs), and where possible, whole viral genomes to identify and characterize the evolution of this lineage over the 13 consecutive months that it was detectable. Findings: The vast majority of 12s rRNAs sequenced from wastewater leaving the identified source building were human. Additionally, we generated over 100 viral RBD and whole genome sequences from wastewater samples containing the cryptic lineage collected between January 2022 and January 2023. These sequences contained a combination of fixed nucleotide substitutions characteristic of Pango lineage B.1.234, which circulated in humans in Wisconsin at low levels from October 2020 to February 2021. Despite this, mutations in the spike gene, and elsewhere, resembled those subsequently found in Omicron variants. Interpretation: We propose that prolonged detection of WI-CL-001 in wastewater represents persistent shedding of SARS-CoV-2 from a single human initially infected by an ancestral B.1.234 virus. The accumulation of convergent “Omicron-like” mutations in WI-CL-001’s ancestral B.1.234 genome likely reflects persistent infection and extensive within-host evolution. Funding: The Rockefeller Foundation, Wisconsin Department of Health Services, Centers for Disease Control and Prevention (CDC), National Institute on Drug Abuse (NIDA), and the Center for Research on Influenza Pathogenesis and Transmission. Research in context: Evidence before this study: To identify other studies that characterized unusual wastewater-specific SARS-CoV-2 lineages, we conducted a PubMed search using the keywords “cryptic SARS-CoV-2 lineages” or “novel SARS-CoV-2 lineages” in addition to “wastewater” on May 9, 2023. From the 18 papers retrieved, only two reported wastewater-specific cryptic lineages. These lineages were identified by members of our author team in wastewater from California, Missouri, and New York City. None of these could be definitively traced to a specific source. A third study in Nevada identified a unique recombinant variant (designated Pango lineage XL) in wastewater, which was also discovered in two clinical specimens from the same community. However, it was unclear whether the clinical specimens collected were from the same individual(s) responsible for the virus detected in the wastewater. To our knowledge, no prior study has successfully traced novel SARS-CoV-2 lineages detected in wastewater back to a specific location. How and where cryptic lineages are introduced into wastewater is not known. The added value of this study: This study documents the presence and likely source of a novel and highly divergent cryptic SARS-CoV-2 lineage detected in Wisconsin wastewater for 13 months. In contrast to previously reported cryptic lineages, we successfully traced the lineage (WI-CL-001) to a single commercial building with approximately 30 employees. The exceptionally high viral RNA concentrations at the source building facilitated the tracing effort and allowed for the sequencing of WI-CL-001’s whole genome, expanding our view of the lineage’s mutational landscape beyond the spike gene. Implications of all the available evidence: WI-CL-001’s persistence in wastewater, its heavily mutated Omicron-like genotype, and its identified point source at a human-occupied commercial building all support the hypothesis that cryptic wastewater lineages can arise from persistently infected humans. Because cryptic wastewater lineages have some amino acid changes that subsequently emerge in circulating viruses, increased global monitoring of such lineages could help forecast variants that may arise in the future.